Tailored eradication therapy based on fecal Helicobacter pylori clarithromycin sensitivities.
Kawai T, Yamagishi T, Yagi K, Kataoka M, Kawakami K, Sofuni A, Itoi T, Sakai Y, Moriyasu F, Osaka Y, Takagi Y, Aoki T, Rimbara E, Noguchi N, Sasatsu M.
Kawai T, et al.
J Gastroenterol Hepatol. 2008 Dec;23 Suppl 2:S171-4. doi: 10.1111/j.1440-1746.2008.05408.x.
J Gastroenterol Hepatol. 2008.
PMID: 19120893
Clinical Trial.